Brief: Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
05/12/2024 14:21
Dec 5 (Reuters) - Hyperfine Inc HYPR.O :
* HYPERFINE ANNOUNCES EXTENSIVE CLINICAL STUDY COVERAGE AT
RSNA
2024, SHOWCASING THE BODY OF EVIDENCE SUPPORTING THE USE OF THE
SWOOP® SYSTEM ACROSS DIFFERENT SITES OF CARE
Source text: ID:nBwzxRC6a
Further company coverage: HYPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsBrief: Hyperfine Inc - Files To Register Up To 1.2 Million Shares Of Class A Common Stock By Selling Securityholders - SEC Filing
Hyperfine Q1 revenue rises as commercial engine accelerates
Brief: Hyperfine, Inc. Q1 EPS USD -0.09
Brief: Horizon Technology Finance Provides $40 Million Loan Facility To Hyperfine
Brief: Hyperfine Enters Loan And Security Agreement With Horizon Technology Finance - SEC Filing